Japan is adopting “Remedisfer” to officially treat Corona

The Japanese government announced Tuesday that it will adopt the antiviral drug Remedisfer as a treatment for patients with the emerging Corona Covid-19 virus in the country, according to the “Sky News Arabia” site.

The drug, which was produced by Gilad Sciences, is expected to be the first Covid-19 approved in Japan, ahead of the influenza vaccine developed by Japan.

Chief Cabinet Secretary Yoshiyeide Soga told reporters that Japan has participated in a joint multinational drug test since March and that it has been participating in investigations outside of Japan, noting that Tokyo has developed a rapid authorization system. of drugs for the emergency use of drugs approved abroad, according to what was reported «The Associated Press.

REMEDIVESIV was originally developed to treat Ebola, but WHO leaks from Chinese clinical trials indicate that the drug has not been effective in chronic conditions.

The drug has also been used to treat SARS and Myers, but its use to treat Covid-19 is still being tested.

Related news
The treatment has been shown to be “effective” in some cases
Japanese Prime Minister: “Afghan” will make a difference by facing SK
Japan is currently testing faviravir, developed by Fujifilm and Toyama, in Japanese hospitals. Experts believe that both remisevir and favipiravir are capable of achieving good results “when used early in the disease.”

“We will do our best to provide effective medications to patients as soon as possible,” said Suga.